A Phencyclidine Recognition Site is Associated with N-methyl-D-aspartate Inhibition of Carbachol-stimulated Phosphoinositide Hydrolysis in Rat Cortical Slices
Overview
Pharmacology
Authors
Affiliations
The effects of N-methyl-D-aspartate (NMDA) on muscarinic receptor-stimulated phosphoinositide (PI) hydrolysis in rat cortical slices were studied. NMDA inhibits carbachol-stimulated PI hydrolysis with an IC50 of 9.8 +/- 1.4 microM and a maximal inhibition of 70% at 100 microM. The inhibitory effect of NMDA is not due to increased metabolism of accumulated inositol phosphates. NMDA inhibition of carbachol-stimulated PI hydrolysis was significantly reduced in the absence of extracellular calcium. Although the inhibitory effect of NMDA is observed in the presence of 1.18 mM Mg2+, the concentration-response curve is slightly shifted to the left (5-fold) in the absence of extracellular Mg2+. Antagonists of NMDA-evoked excitations were effective inhibitors of the NMDA modulation of PI hydrolysis, including the competitive antagonist 2-amino-5-phosphonopentanoic acid and the noncompetitive antagonist MK-801. The rank order of potencies of the antagonists were MK-801 greater than phencyclidine = (-)-cyclazocine greater than ketamine = etoxadrol greater than N-allylnormetazocine greater than 2-amino-5-phosphonopentanoic acid. (+)-MK-801 and (-)-cyclazocine were more potent inhibitors, by 4-5-fold, of the NMDA response than their respective isomers, whereas N-allylnormetazocine isomers were approximately equipotent antagonists. The activity of dexoxadrol against NMDA inhibition of carbachol-stimulated PI hydrolysis could not be determined because of its antimuscarinic effects. The rank order of potencies of antagonists, the stereoselectivity of the isomers of MK-801, cyclazocine, and N-allylnormetazocine, and Mg2+ sensitivity of the NMDA inhibitory response suggest that a phencyclidine binding similar to the one located in the cation channel gated by NMDA receptors is associated with the NMDA receptor that modulates muscarinic-stimulated PI hydrolysis.
Boje K, Lakhman S Neurochem Res. 1998; 23(9):1167-74.
PMID: 9712186 DOI: 10.1023/a:1020773917240.
Lee H, Huang C Neurochem Res. 1997; 22(5):607-14.
PMID: 9131640 DOI: 10.1023/a:1022426204583.
Minisclou C, Benavides J, Claustre Y Neurochem Res. 1995; 20(9):977-83.
PMID: 8570018 DOI: 10.1007/BF00995549.
Myles M, Fain J Neurochem Res. 1995; 20(9):1057-64.
PMID: 8570010 DOI: 10.1007/BF00995560.
Birrell G, Marcoux F Br J Pharmacol. 1993; 109(2):379-85.
PMID: 8395285 PMC: 2175676. DOI: 10.1111/j.1476-5381.1993.tb13580.x.